Inna Kot YS Biopharma ( NASDAQ: YS ) said on Friday that the biopharmaceutical company is changing its legal name to LakeShore Biopharma. Effective May 28 market open, the ticker symbol of the ordinary shares and warrants will change to LSB and LSBPW, respectively. "We have decided to change our company name to LakeShore Biopharma to align with our global market positioning and international brand image," said President David Shao.
Source: Press Release More on YS Biopharma YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript YS Biopharma appoints Dave Chenn as interim CEO YS Biopharma announces full repayment of $40M loan facility Seeking Alpha’s Quant Rating on YS Biopharma Historical earnings data for YS Biopharma.
